DBV Technologies S.A.

NASDAQ:DBVT

Biotechnology

Healthcare
$9.99 -0.95%

-$0.16 today

Market cap
$238.98M
Beta
-0.22
P/E (TTM)
-8.3
EPS (TTM)
-$0.39
52W Low $8.50High $26.19

Volume 0.17M

Average 0.24M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$121.18M

FY 2025 · Annual

Investing Cash Flow

-$1.37M

FY 2025 · Annual

Financing Cash Flow

$276.18M

FY 2025 · Annual

+46949.7% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(97.81M)(96.27M)(72.73M)(113.92M)(146.95M)
Depreciation & Amortization8.38M13.16M(14M)(925K)3.19M
Deferred Income Tax184K0000
Stock-Based Compensation3.12M5.03M6.02M4.62M5.39M
Change in Working Capital(22.77M)22.32M953K5.75M1.34M
Accounts Receivables2.15M0000
Inventory(16.18M)000(16.11M)
Accounts Payables(7.56M)3.46M8.42M272K15.83M
Other Working Capital(1.19M)18.86M(7.47M)5.48M1.62M
Other Non-Cash Items656K66K99K(3K)15.84M
Operating Cash Flow(108.24M)(55.7M)(79.65M)(104.47M)(121.18M)
Capital Expenditures(918K)(754K)(677K)(2.34M)(533.64K)
Acquisitions (Net)511.01K7.61K000
Purchases of Investments(119K)(123K)(285K)00
Sales of Investments(511.01K)770K154K00
Other Investing Activities604K(611)(131K)1.58M(829.34K)
Investing Cash Flow(433K)(100K)(808K)(757K)(1.37M)
Debt Repayment(582.92K)(474K)000
Common Stock Issued978K194.59M6.92M634K277.04M
Common Stock Repurchased00(154K)(47K)0
Dividends Paid00000
Other Financing Activities(121.08K)(20K)00(854.56K)
Financing Cash Flow274K194.1M6.77M587K276.18M
Effect of Forex Changes(10.65M)(6.5M)5.87M(4.27M)8.08M
Net Change in Cash(119.05M)131.9M(67.83M)(108.91M)161.71M
Free Cash Flow(109.16M)(56.45M)(80.33M)(106.82M)(121.18M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$146.9M
+ D&A$3.2M
+ Stock-Based Comp$5.4M
+ Deferred Tax$0
+ Working Capital$1.3M
+ Other Non-Cash$15.8M
= Operating Cash Flow-$121.2M
- Capex-$533.6K
= Free Cash Flow-$121.2M

Analysis

FY2025 free cash flow is -$121.2M. FCF conversion is 82.5% of net income. Operating cash flow was -$121.2M, with capex of -$533.6K. The largest bridge item is Other Non-Cash at $15.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
SC 13G/ASC 13G/A filingNov 12, 2026
8-KCurrent reportOct 28, 2026
10-QQuarterly reportOct 28, 2026
8-KCurrent reportSep 30, 2026

Does DBVT generate free cash flow?

DBV Technologies S.A. (DBVT) generated -$121.18M of free cash flow in fiscal 2025.

How much operating cash flow does DBVT produce?

Operating cash flow was -$121.18M, before capital expenditures of $533,642.00.